Source: Journal of Clinical Oncology. Conference titles: ASCO Annual Meeting. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (TERAPIA), QUIMIOTERAPIA, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO (ETIOLOGIA), ANTINEOPLÁSICOS (CLASSIFICAÇÃO;EFEITOS ADVERSOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Daniel Ciampi de et al. A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/3575?sid=69988bce-10fd-4808-a054-d0c1d39d5fff. Acesso em: 26 set. 2024. , 2015APA
Andrade, D. C. de, Teixeira, M. J., Galhardoni, R., Ferreira, K. A. S. L., Malieno, P. B., Scisci, N., et al. (2015). A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/3575?sid=69988bce-10fd-4808-a054-d0c1d39d5fffNLM
Andrade DC de, Teixeira MJ, Galhardoni R, Ferreira KASL, Malieno PB, Scisci N, Riechelmann RP, Teixeira WGJ, Saragiotto DF, Silva VA, Raicher I, Castro I de, Parravano D, Fukushima JT, Lefaucheur J-P, Bouhassira D, Macarenco RS e S, Mello ES de, Hoff PM. A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx) [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 set. 26 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/3575?sid=69988bce-10fd-4808-a054-d0c1d39d5fffVancouver
Andrade DC de, Teixeira MJ, Galhardoni R, Ferreira KASL, Malieno PB, Scisci N, Riechelmann RP, Teixeira WGJ, Saragiotto DF, Silva VA, Raicher I, Castro I de, Parravano D, Fukushima JT, Lefaucheur J-P, Bouhassira D, Macarenco RS e S, Mello ES de, Hoff PM. A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx) [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 set. 26 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/3575?sid=69988bce-10fd-4808-a054-d0c1d39d5fff
